StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$6.88−0.14 (-1.99%)

Close on Nov 18, 2026Market cap $249.69MP/E –Yield –

Evommune shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Evommune's shares outstanding was 36M at Sep 30, 2026. For fiscal 2025 it was 6M, up 306.9% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20256M+306.9%
FY2024Dec 31, 20242M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202636M+2257.8%
Q2 FY2026Jun 30, 202636M+2254.2%
Q1 FY2026Mar 31, 202634M+2103.2%
Q3 FY2025Sep 30, 20252M+1.6%
Q2 FY2025Jun 30, 20252M–
Q1 FY2025Mar 31, 20252M–
Q4 FY2024Dec 31, 20242M–
Q3 FY2024Sep 30, 20242M–

More Evommune figures

See a number that looks wrong?